Fred Jacobson
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 10%
- HER2/EGFR in Cancer Research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Protein purification and stability 8
- Co-authors
- Mary E. M. Cromwell (1 shared paper)Michael Tae-jong Kim (4 shared papers)Ian E. Krop (1 shared paper)Stuart G. Lutzker (1 shared paper)Wei Yu (1 shared paper)Howard A. Burris (1 shared paper)Suzanne Fields Jones (1 shared paper)Jay Tibbitts (1 shared paper)
- Journals
- Bioconjugate Chemistry (3 papers)Journal of Pharmaceutical Sciences (1 paper)Journal of Clinical Oncology (1 paper)mAbs (1 paper)interactions (1 paper)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Fred Jacobson
10 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 75
- Radiology, Nuclear Medicine and Imaging 371
- Oncology 258
- Immunology 202
- Molecular Biology 645
- Biomaterials 71
Countries citing papers authored by Fred Jacobson
This map shows the geographic impact of Fred Jacobson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Jacobson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Jacobson more than expected).
Fields of papers citing papers by Fred Jacobson
This network shows the impact of papers produced by Fred Jacobson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Jacobson. The network helps show where Fred Jacobson may publish in the future.
Co-authors
The 25 scholars most cited alongside Fred Jacobson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 627 | |
| 2 | 2010 | 492 | |
| 3 | 2014 | 128 | |
| 4 | 2008 | 66 | |
| 5 | 2019 | 43 | |
| 6 | 2009 | 33 | |
| 7 | 2016 | 29 | |
| 8 | 2023 | 26 | |
| 9 | 2016 | 13 | |
| 10 | 2017 | 3 | |
| 11 | 2013 | 0 |
About Fred Jacobson
Fred Jacobson is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Immunology, Human-Computer Interaction and Analytical Chemistry, having authored 11 papers that have together received 1.5k indexed citations. Recurring topics across this work include Protein purification and stability (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Biosimilars and Bioanalytical Methods (2 papers), Analytical Methods in Pharmaceuticals (1 paper), Innovative Human-Technology Interaction (1 paper), Usability and User Interface Design (1 paper), Interactive and Immersive Displays (1 paper) and Advanced Proteomics Techniques and Applications (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (371 citations), Oncology (258 citations), Immunology (202 citations), Molecular Biology (645 citations) and Biomaterials (71 citations). Fred Jacobson has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Mary E. M. Cromwell, Michael Tae-jong Kim, Ian E. Krop, Stuart G. Lutzker, Wei Yu, Howard A. Burris, Suzanne Fields Jones, Jay Tibbitts, Muralidhar Beeram and Joo‐Hee Yi. Their work appears in journals such as Bioconjugate Chemistry, Journal of Pharmaceutical Sciences, Journal of Clinical Oncology, mAbs and interactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.